Cargando…

Appearances of Premature Atrial and Ventricular Contractions After Switching From Brand Name to Generic Cibenzoline

In antiarrhythmic drugs, the therapeutic window is narrower than in other drugs. Brand name and generic drugs do not use the same inactive ingredients and binder substances. We report a 78-year-old male patient who had been treated for asymptomatic atrial fibrillation and atrial/ventricular prematur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oguri, Gaku, Fujiu, Katsuhito, Oshima, Tsukasa, Komuro, Issei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387168/ https://www.ncbi.nlm.nih.gov/pubmed/37525781 http://dx.doi.org/10.7759/cureus.41164

Ejemplares similares

Cryoballoon ablation for paroxysmal atrial fibrillation mildly improves lung function: An observational study
por: Oguri, Gaku, et al.
Publicado: (2023)

What is the mechanism of irregular pacing spikes? Pacing failure, sensing failure, or something else? A case report
por: Oguri, Gaku, et al.
Publicado: (2020)

Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023)

Fluoroless and contrast-free catheter ablation without a lead apron in routine clinical practice
por: Matsubara, Takumi J., et al.
Publicado: (2020)

Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2017)

Uninterrupted Direct Oral Anticoagulants Without a Change in Regimen for Catheter Ablation for Atrial Fibrillation Is an Acceptable Protocol
por: Oshima, Tsukasa, et al.
Publicado: (2021)

The estimated glomerular filtration rate predicts pacemaker-induced cardiomyopathy
por: Oida, Mitsunori, et al.
Publicado: (2023)

The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013)

Generic versus brand-name drugs used in cardiovascular diseases
por: Manzoli, Lamberto, et al.
Publicado: (2015)

Generics versus brand-named drugs for glaucoma: the debate continues
por: Bhartiya, Shibal, et al.
Publicado: (2020)

Elemental impurities analysis in name-brand and generic omeprazole drug samples
por: Pinheiro, Fernanda C., et al.
Publicado: (2020)

Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
por: Yang, Ping, et al.
Publicado: (2021)

Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers
por: Leclerc, Jacinthe, et al.
Publicado: (2020)

What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice
por: Steinman, Michael A., et al.
Publicado: (2007)

The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
por: Sarpatwari, Ameet, et al.
Publicado: (2016)

The influence of His bundle pacing on tricuspid valve functioning using three-dimensional echocardiography
por: Hasumi, Eriko, et al.
Publicado: (2018)

Asymptomatic Long-term Cardiac Perforation by a Pacemaker Lead
por: Nakao, Tomoko, et al.
Publicado: (2019)

Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation
por: Nakanishi, Koki, et al.
Publicado: (2023)

Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation
por: Ochi, Nobuaki, et al.
Publicado: (2014)

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
por: Desai, Rishi J, et al.
Publicado: (2018)

Sustained Suppression of Premature Ventricular Contractions by a Three-Month Pacing Adjustment
por: Sackin, Henry, et al.
Publicado: (2022)

Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy
por: Narita, Koichi, et al.
Publicado: (2020)

Prevalence, Associated Factors, and Echocardiographic Estimation of Left Atrial Hypertension in Patients With Atrial Fibrillation
por: Mukai, Yasuhiro, et al.
Publicado: (2023)

Potential Clinical and Economic Impact of Switching Branded Medications to Generics
por: Straka, Robert J., et al.
Publicado: (2017)

Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels
por: Brito, Juan P., et al.
Publicado: (2020)

North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
por: Malvankar-Mehta, Monali S, et al.
Publicado: (2019)

Comparative efficacy of generic nifedipine versus brand‐name amlodipine for hypertension management in Taiwan
por: Lee, Hao‐Wei, et al.
Publicado: (2022)

A Premature Ventricular Contraction Associated With Transient Worsening Pulsus Alternans: A Case Report
por: Trongtorsak, Angkawipa, et al.
Publicado: (2021)

Rapid Dilatation of False Lumen in a Patient With Chronic Aortic Dissection Under Suspicion of Anticoagulation Therapy-Induced Recanalization
por: Yamada, Shintaro, et al.
Publicado: (2020)

Effect of oval foramen restriction and premature contraction of the arterial catheter on right heart function of fetuses and infants
por: Liu, Hongqiang, et al.
Publicado: (2023)

Recurrence of atrial fibrillation after switching from brand to generic atenolol
por: Gallelli, Luca, et al.
Publicado: (2015)

Increased frequency of angina attacks caused by switching a brand-name vasodilator to a generic vasodilator in patients with vasospastic angina: Two case reports
por: Goto-Semba, Remi, et al.
Publicado: (2018)

Quality of Reporting of Bioequivalence Trials Comparing Generic to Brand Name Drugs: A Methodological Systematic Review
por: van der Meersch, Amélie, et al.
Publicado: (2011)

Effect of Generic vs. Brand-Name Meropenem on Mortality in a Colombian Hospital’s Intensive Care Unit
por: Feinstein, Max, et al.
Publicado: (2017)

Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C
por: Tang, L., et al.
Publicado: (2018)

Generic versus brand-name over-the-counter analgesics: knowledge and attitudes among Swedish pharmacy customers
por: Håkonsen, Helle, et al.
Publicado: (2020)

Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018
por: Lin, Shuo-yu, et al.
Publicado: (2021)

Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia
por: Ordóñez, Karen, et al.
Publicado: (2019)

Safety Monitoring for Obstructive Hypertrophic Cardiomyopathy During Exercise
por: Nakayama, Atsuko, et al.
Publicado: (2020)

Cholecystitis and Cholangitis during Continuous Renal Replacement Therapy in a Patient with Retroperitoneal Hemorrhage Requiring Large Amounts of Contrast Medium for the Assessment and Intervention
por: Goto, Kohsaku, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h2ge0v5qrabf3u0kcdmhvkvot6